Trial to Investigate the Influence of the Homeopathic Remedy Naja-comp on Stroke Therapy in Geriatric Rehabilitation
NCT ID: NCT01048411
Last Updated: 2020-12-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
344 participants
INTERVENTIONAL
2006-01-31
2009-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The homeopathic remedy 'naja-comp' will decrease complications during geriatric rehabilitation measured by rate of unplanned discharge to hospital.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Naja-comp.
s.c. injection of naja comp (homeopathic remedy) three times a week
Naja-comp.
homeopathic remedy
Placebo
s.c. injection of placebo (NaCl-solution) three times a week
Placebo
s.c. injection of NaCl-solution three times a week
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Naja-comp.
homeopathic remedy
Placebo
s.c. injection of NaCl-solution three times a week
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* stroke older than 60 days
* missing consent for participation
* participation at other clinical trials
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Erlangen-Nürnberg Medical School
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University of Erlangen-Nuernberg, Institute for Biomedicine of Aging
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Cornel Sieber, Professor
Role: STUDY_CHAIR
Univerity of Erlangen-Nuernberg, Director of the Institute for Biomedicine of Aging
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
KWA Stift Rottal
Bad Griesbach, Bavaria, Germany
Alexander von Humdoldt-Klijnik
Bad Steben, Bavaria, Germany
Kreiskrankenhaus Haag - Fachklinik für Geriatrische Rehabilitation
Haag in Oberbayern, Bavaria, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2004-001760-46
Identifier Type: EUDRACT_NUMBER
Identifier Source: secondary_id
naja-comp-1-trial
Identifier Type: -
Identifier Source: org_study_id